6 videos for Suk
MRI’s can miss 40% of MS lesions? We didn’t know that.
What is a biosimilar and what does that mean for MS treatments?
Consultant Neurologist, Professor of Neurology
Shift.ms @ ECTRIMS – Day 2 highlights
Dr Daniel Ontaneda talks about treating newly diagnosed RRMS
Professor of Neurology
Prof Heinz Wiendl talks about the future of MS treatment, communication and more
Search for content from one of our Reporters